Ankylosing Spondylitis Disease Activity Score (ASDAS) by anti-drug

Axial Spondyloarthritis: Clinical Characteristics, Epidemiology, and General Approaches to Management - European Medical Journal

WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents

Disease Control Data, Ankylosing Spondylitis

Assessment and Monitoring, Ankylosing Spondylitis

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study, BMC Musculoskeletal Disorders

Investigation of changes in ankylosing spondylitis disease activity through 2021 COVID-19 wave in Taiwan by using electronic medical record management system

Current health resources required for the management of ankylosing spondylitis in developing areas of China

Mean Ankylosing Spondylitis Disease Activity Score with C‐reactive

Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors

Nutrients, Free Full-Text

PDF) The Value of the Ankylosing Spondylitis Disease Activity Score (Asdas) in Evaluating Disease Activity in Patients with Axial Spondyloarthritis

Ankylosing spondilitis

SciELO - Brasil - Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil Maintained activity in ankylosing spondylitis patients treated

Performance of 3 Composite Measures for Disease Activity in Peripheral Spondyloarthritis